The Beta Klotho pipeline drugs market research report outlays comprehensive information on the Beta Klotho targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Beta Klotho pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Gastrointestinal, Metabolic Disorders, Musculoskeletal Disorders, and Respiratory which include the indications Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Type 2 Diabetes, Obesity, Fibrosis, and Idiopathic Pulmonary Fibrosis. It also reviews key players involved in Beta Klotho targeted therapeutics development with respective active and dormant or discontinued products.
The Beta Klotho pipeline targets constitutes close to 12 molecules. Out of which, approximately 11 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical, and Discovery stages are 1, 5, 2, 2, and 1 respectively. Similarly, the universities portfolio in Preclinical comprises 1 molecule.
Beta Klotho overview
Beta Klotho (KLB) is a single-pass transmembrane protein and is a fundamental component in fibroblast growth factor receptor (FGFR) signaling, as it serves as an obligatory coreceptor for the endocrine hormones fibroblast growth factor 19 (FGF19) and fibroblast growth factor 21 (FGF21).
For a complete picture of Beta Klotho’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.